APA (7th ed.) Citation

Sznol, M., & Hassel, J. C. (2016). Safety profile of nivolumab (NIVO) and ipilimumab (IPI) combination therapy in patients (pts) with advanced melanoma (MEL). Annals of oncology, 27, . https://doi.org/10.1093/annonc/mdw379.18

Chicago Style (17th ed.) Citation

Sznol, Mario, and Jessica C. Hassel. "Safety Profile of Nivolumab (NIVO) and Ipilimumab (IPI) Combination Therapy in Patients (pts) with Advanced Melanoma (MEL)." Annals of Oncology 27 (2016). https://doi.org/10.1093/annonc/mdw379.18.

MLA (9th ed.) Citation

Sznol, Mario, and Jessica C. Hassel. "Safety Profile of Nivolumab (NIVO) and Ipilimumab (IPI) Combination Therapy in Patients (pts) with Advanced Melanoma (MEL)." Annals of Oncology, vol. 27, 2016, https://doi.org/10.1093/annonc/mdw379.18.